CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 137 filers reported holding CHINA BIOLOGIC PRODS INC in Q1 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $233,582,000 | +24.0% | 2,065,269 | +9.8% | 0.03% | +20.8% |
| Q1 2017 | $188,300,000 | +18.8% | 1,880,549 | +27.5% | 0.02% | +14.3% |
| Q4 2016 | $158,533,000 | -3.5% | 1,474,444 | +11.7% | 0.02% | -4.5% |
| Q3 2016 | $164,270,000 | +9.1% | 1,319,652 | -6.8% | 0.02% | +4.8% |
| Q2 2016 | $150,507,000 | -4.1% | 1,415,606 | +3.3% | 0.02% | -4.5% |
| Q1 2016 | $156,956,000 | -7.7% | 1,371,031 | +14.9% | 0.02% | -4.3% |
| Q4 2015 | $169,982,000 | +72.6% | 1,193,193 | +8.8% | 0.02% | +64.3% |
| Q3 2015 | $98,478,000 | -11.7% | 1,096,393 | +13.3% | 0.01% | 0.0% |
| Q2 2015 | $111,478,000 | +198.4% | 968,032 | +147.5% | 0.01% | +180.0% |
| Q1 2015 | $37,362,000 | +367.8% | 391,185 | +117.8% | 0.01% | +400.0% |
| Q2 2014 | $7,987,000 | – | 179,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ariose Capital Management Ltd | 88,655 | $10,149,000 | 9.57% |
| WARBURG PINCUS LLC | 4,087,200 | $467,903,000 | 8.91% |
| RUDMAN ERROL M | 64,001 | $7,327,000 | 4.96% |
| INDUS CAPITAL PARTNERS, LLC | 378,518 | $43,333,000 | 4.22% |
| OBERWEIS ASSET MANAGEMENT INC/ | 90,105 | $10,315,000 | 2.98% |
| Ativo Capital Management LLC | 85,623 | $9,802,000 | 2.66% |
| Sensato Investors LLC | 113,296 | $12,970,000 | 2.31% |
| Cormorant Asset Management, LP | 111,500 | $12,765,000 | 1.92% |
| BARING ASSET MANAGEMENT Ltd | 128,784 | $14,743,000 | 1.23% |
| Visium Asset Management, LP | 484,619 | $55,479,000 | 0.94% |